Financial Flexion Therapeutics Reports Second-Quarter 2016 Financial Results byJosh SandbergAugust 3, 2016
Recon Flexion Therapeutics Adds Three New Executives in Key Roles to Support the Planned Commercial Launch of Zilretta™ byJosh SandbergJuly 7, 2016
Financial Flexion Therapeutics Announces Proposed Public Offering of Common Stock byJosh SandbergJune 8, 2016
